659 related articles for article (PubMed ID: 28161078)
1. Erectile Dysfunction in Heme-Deficient Nitric Oxide-Unresponsive Soluble Guanylate Cyclase Knock-In Mice.
Decaluwé K; Pauwels B; Boydens C; Thoonen R; Buys ES; Brouckaert P; Van de Voorde J
J Sex Med; 2017 Feb; 14(2):196-204. PubMed ID: 28161078
[TBL] [Abstract][Full Text] [Related]
2. Prolonged therapy with the soluble guanylyl cyclase activator BAY 60-2770 restores the erectile function in obese mice.
Silva FH; Leiria LO; Alexandre EC; Davel AP; Mónica FZ; De Nucci G; Antunes E
J Sex Med; 2014 Nov; 11(11):2661-70. PubMed ID: 25196910
[TBL] [Abstract][Full Text] [Related]
3. Oximes induce erection and are resistant to oxidative stress.
Pauwels B; Boydens C; Brouckaert P; Van de Voorde J
J Sex Med; 2015 Apr; 12(4):906-15. PubMed ID: 25689429
[TBL] [Abstract][Full Text] [Related]
4. Modulation of soluble guanylate cyclase for the treatment of erectile dysfunction.
Lasker GF; Pankey EA; Kadowitz PJ
Physiology (Bethesda); 2013 Jul; 28(4):262-9. PubMed ID: 23817801
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effects of BAY 60-4552 and vardenafil on relaxation of corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.
Albersen M; Linsen L; Tinel H; Sandner P; Van Renterghem K
J Sex Med; 2013 May; 10(5):1268-77. PubMed ID: 23421435
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of Cyclic GMP Export by Multidrug Resistance Protein 4: A New Strategy to Treat Erectile Dysfunction?
Boydens C; Pauwels B; Vanden Daele L; Van de Voorde J
J Sex Med; 2017 Apr; 14(4):502-509. PubMed ID: 28258955
[TBL] [Abstract][Full Text] [Related]
7. Exploring the potential of NO-independent stimulators and activators of soluble guanylate cyclase for the medical treatment of erectile dysfunction.
Gur S; Kadowitz PJ; Hellstrom WJ
Curr Pharm Des; 2010 May; 16(14):1619-33. PubMed ID: 20201788
[TBL] [Abstract][Full Text] [Related]
8. Reduced vascular responses to soluble guanylyl cyclase but increased sensitivity to sildenafil in female rats with type 2 diabetes.
Goulopoulou S; Hannan JL; Matsumoto T; Ogbi S; Ergul A; Webb RC
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H297-304. PubMed ID: 25957216
[TBL] [Abstract][Full Text] [Related]
9. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
10. Heme deficiency of soluble guanylate cyclase induces gastroparesis.
Cosyns SM; Dhaese I; Thoonen R; Buys ES; Vral A; Brouckaert P; Lefebvre RA
Neurogastroenterol Motil; 2013 May; 25(5):e339-52. PubMed ID: 23551931
[TBL] [Abstract][Full Text] [Related]
11. Relaxant and antioxidant capacity of the red wine polyphenols, resveratrol and quercetin, on isolated mice corpora cavernosa.
Boydens C; Pauwels B; Decaluwé K; Brouckaert P; Van de Voorde J
J Sex Med; 2015 Feb; 12(2):303-12. PubMed ID: 25443137
[TBL] [Abstract][Full Text] [Related]
12. BAY58-2667 Activates Different Soluble Guanylyl Cyclase Species by Distinct Mechanisms that Indicate Its Principal Target in Cells is the Heme-Free Soluble Guanylyl Cyclase-Heat Shock Protein 90 Complex.
Dai Y; Stuehr DJ
Mol Pharmacol; 2023 May; 103(5):286-296. PubMed ID: 36868790
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterisation of the relaxation induced by the soluble guanylate cyclase activator, BAY 60-2770 in rabbit corpus cavernosum.
Estancial CS; Rodrigues RL; De Nucci G; Antunes E; Mónica FZ
BJU Int; 2015 Oct; 116(4):657-64. PubMed ID: 25715977
[TBL] [Abstract][Full Text] [Related]
14. Role of the soluble guanylyl cyclase alpha1-subunit in mice corpus cavernosum smooth muscle relaxation.
Nimmegeers S; Sips P; Buys E; Decaluwé K; Brouckaert P; Van de Voorde J
Int J Impot Res; 2008; 20(3):278-84. PubMed ID: 18059500
[TBL] [Abstract][Full Text] [Related]
15. The sGC activator BAY 60-2770 has potent erectile activity in the rat.
Lasker GF; Pankey EA; Frink TJ; Zeitzer JR; Walter KA; Kadowitz PJ
Am J Physiol Heart Circ Physiol; 2013 Jun; 304(12):H1670-9. PubMed ID: 23585129
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ferrochelatase impairs vascular eNOS/NO and sGC/cGMP signaling.
Zhang B; Alruwaili N; Kandhi S; Deng W; Huang A; Wolin MS; Sun D
PLoS One; 2018; 13(7):e0200307. PubMed ID: 29985945
[TBL] [Abstract][Full Text] [Related]
17. Vardenafil improves penile erection in type 2 diabetes mellitus patients with erectile dysfunction: role of tropomyosin.
Zamorano-León JJ; Olivier C; de Las Heras N; Mateos-Cáceres PJ; Brime Menéndez R; Rodríguez-Sierra P; Martín Palacios N; Manso LS; Modrego J; Segura A; Macaya C; López-Farré AJ
J Sex Med; 2013 Dec; 10(12):3110-20. PubMed ID: 24112450
[TBL] [Abstract][Full Text] [Related]
18. The soluble guanylate cyclase stimulator riociguat and the soluble guanylate cyclase activator cinaciguat exert no direct effects on contractility and relaxation of cardiac myocytes from normal rats.
Reinke Y; Gross S; Eckerle LG; Hertrich I; Busch M; Busch R; Riad A; Rauch BH; Stasch JP; Dörr M; Felix SB
Eur J Pharmacol; 2015 Nov; 767():1-9. PubMed ID: 26407652
[TBL] [Abstract][Full Text] [Related]
19. Preserved activity of soluble guanylate cyclase (sGC) in iliac artery from middle-aged rats: Role of sGC modulators.
Justo AFO; de Oliveira MG; Calmasini FB; Alexandre EC; Bertollotto GM; Jacintho FF; Antunes E; Mónica FZ
Nitric Oxide; 2021 Jan; 106():9-16. PubMed ID: 33122152
[TBL] [Abstract][Full Text] [Related]
20. The nitric oxide-soluble guanylate cyclase-cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase.
Benza RL; Grünig E; Sandner P; Stasch JP; Simonneau G
Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38508664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
